Content Status
Type
H5Content
Content
Type of regimen |
Interim outcome |
Expected duration (in months) from treatment initiation when the treatment outcome to be updated |
Cohort for analysis of final outcome |
DS-TB regimen |
2 months |
12 months |
12 months before |
H mono/poly DR-TB regimen |
6 months |
12 months |
12 months before |
Shorter oral Bedaquiline - containing MDR/RR-TB regimen |
6 months |
12 months |
15 months before |
Longer oral M/XDR-TB regimen |
9 months |
24 months |
24 months before |
Content Creator
Reviewer
- Log in to post comments